CV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CapsoVision Inc (CV) is not a strong buy for a beginner, long-term investor at this time. While the company has shown some positive developments, such as increased revenue and improved EPS, the stock's technical indicators and lack of clear trading signals suggest a neutral stance. Additionally, the stock has experienced significant recent volatility, which may not align with the investor's long-term, stable growth strategy.
The MACD is below 0 and negatively expanding, indicating bearish momentum. RSI is neutral at 25.06, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 5.584), but the overall technical setup does not suggest a strong buy signal.
Analysts have raised price targets recently, with Roth Capital increasing its target to $11 from $
The company closed a $14M private placement to support R&D and pipeline advancements.
Revenue increased by 13.50% YoY in Q4 2025.
Regular market change showed a significant drop of -9.55%.
Gross margin dropped slightly YoY to 49.87%.
MACD and RSI indicators do not show bullish momentum.
No recent news or significant trading trends from hedge funds or insiders.
In Q4 2025, revenue increased by 13.50% YoY to $3.918M, net income improved by 59.39% YoY but remains negative at -$7.394M, and EPS improved by 60% YoY to -0.16. However, gross margin dropped slightly to 49.87%.
Analysts have mixed views. Roth Capital raised its price target to $11 from $7 and maintains a Buy rating, citing the company's private placement and pipeline advancements. Benchmark lowered its price target to $10 from $14, maintaining a Speculative Buy rating, citing reduced revenue estimates for 2026 and 2027.
